Explore how Cincinnati Children’s neurologists are addressing social determinants of health to improve outcomes for patients with rare neuroimmune disorders.
User-defined virtual sensor beamforming pinpoints seizure onset zones beyond the temporal lobe, providing a solution for locating epilepsy sources other methods miss.
Cincinnati Children’s leads phase 3 trials of CAP-1002, a cell therapy showing promise for late-stage Duchenne muscular dystrophy patients with limited treatment options.
Discover how Cincinnati Children’s pioneered a surgical approach enabling life-changing gene therapy for AADC deficiency—the youngest patient now thrives.
Discover how Cincinnati Children’s Tuberous Sclerosis Complex Clinic is expanding neurodevelopmental and neuropsychiatric care, including remote behavioral interventions for families nationwide.
Cincinnati Children’s skull base surgery program earns NASBS Multidisciplinary Team of Distinction, showcasing pediatric experts advancing care through collaboration and innovation.
Recent research from Cincinnati Children’s highlights how socioeconomic factors—such as education, income, and insurance—play a critical role in shaping access and outcomes for pediatric MS care.
New research explores how modulating V2a neurons may activate accessory respiratory muscles, offering insight into improving breathing in neuromuscular disease.
Cincinnati Children’s offers a team-based approach to surgical tone management in cerebral palsy, including SDR and combined rhizotomy techniques.
Cincinnati Children’s launches a microsurgical skills lab and community advisory board, advancing hands‑on training and support for the next generation of neurosurgeons.